RotaTeq 2300000 [iU]/2mL (Rotavirus Vaccine, Live, Oral, Pentavalent SOLUTION) 2300000 [iU]/2mL

RotaTeq 2300000 [iU]/2mL is a live, oral rotavirus vaccine designed to help prevent rotavirus infection in infants. This pentavalent vaccine is administered orally and is suitable for use in young children.

Strength

2300000 [iU]/2mL

Pack Size

25 POUCH in 1 CARTON (0006-4047-20) / 1 TUBE in 1 POUCH (0006-4047-02) / 2 mL in 1 TUBE (0006-4047

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RotaTeq is primarily used to protect infants and young children from rotavirus, a common cause of severe diarrhea and vomiting. The vaccine helps the immune system recognize and fight rotavirus, reducing the risk of severe illness. It is typically administered in a series of doses to ensure effective protection.

Side Effects

After receiving RotaTeq, some children may experience mild side effects such as fever, diarrhea, or vomiting. These effects are usually temporary and resolve on their own. Severe reactions are rare but should be reported to a healthcare provider.

Precautions & Warnings

RotaTeq should be stored and handled according to the manufacturer's guidelines to maintain its effectiveness. It is important to follow the recommended dosing schedule and consult a healthcare provider for any concerns or questions about the vaccine.

Avoid Interactions

RotaTeq may interact with other medications or vaccines. It is important to inform a healthcare provider about all current medications and vaccines before receiving RotaTeq. Specific interactions should be discussed with a healthcare professional.

Frequently Asked Questions

RotaTeq is used to help prevent rotavirus infection in infants and young children, which can cause severe diarrhea and vomiting.

RotaTeq is administered orally in a liquid form, typically given in a series of doses.

Common side effects may include mild fever, diarrhea, or vomiting, which usually resolve on their own.

RotaTeq can be given with other vaccines, but it is important to follow the recommended dosing schedule and consult a healthcare provider.

RotaTeq should be stored according to the manufacturer's guidelines to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.